Mutations in the NF1 gene can also alter cellular growth and neural development, resulting in neurofibromatosis type 1, an autosomal dominant disorder that affects approximately one in 3,500 newborns worldwide (Philpott et al., 2017; Stumpf et al., 1988). This evidence concerns the gene NF1 and neurofibromatosis type 1.